1. Is the pathogenesis of ischemic heart disease different between men and women?

   • Gerald M. Pohost

   Editor’s Commentary Pages: 241 - 242

2. Web alert

   • Ira S. Nash

   News Pages: 243 - 244

3. Surgical, medical, and percutaneous therapies for patients with multivessel coronary artery disease

   • Murtuza J. Ali
   • Ravin Davidoff

   OriginalPaper Pages: 247 - 254

4. Revascularization for patients with severe coronary artery disease and left ventricular dysfunction

   • Tapas Ghose
   • Randall C. Thompson

   OriginalPaper Pages: 255 - 260

5. Primary prevention for patients with intermediate framingham Risk Scores

   • Jason B. Thompson
   • Juan J. Rivera
   • Peter Danyi

   OriginalPaper Pages: 261 - 266

6. Clopidogrel treatment surrounding percutaneous coronary intervention: When should it be started and stopped?

   • Alanna Coolong
   • Laura Mauri

   OriginalPaper Pages: 267 - 271

7. Treatment options for refractory angina in patients who are not candidates for revascularization

   • C. Richard Conti

   OriginalPaper Pages: 272 - 276

8. Clinical trials report

   • John H. Alexander
   • Robert A. Harrington

   OriginalPaper Pages: 279 - 281

9. Current status of risk stratification methods in acute coronary syndromes

   • Raphael See
   • James A. de Lemos

   OriginalPaper Pages: 282 - 288

10. Special issues when caring for the older person with acute coronary syndromes

    • Rahman Shah
    • JoAnne Micale Foody

    OriginalPaper Pages: 289 - 295

11. Acute coronary syndromes in patients with renal disease: What are the issues?

    • Carmelo J. Panetta
    • Charles A. Herzog
    • Timothy D. Henry

    OriginalPaper Pages: 296 - 300

12. Antiplatelet resistance with aspirin and clopidogrel: Is it real and does it matter?

    • Wai-Hong Chen

    OriginalPaper Pages: 301 - 306